The autumn wave of coronavirus is sweeping across Germany. Those affected mainly suffer from coughs, colds, sore throats and ...
But the court ruled another similar patent was valid and that Pfizer and BioNTech’s Comirnaty vaccine had infringed it, ...
Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...
Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...
A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to continue at the Court of Appeal. In July, a High Court judge delivered a mixed ...
The Department of Health and Human Services will soon restart its program of offering free rapid tests for the virus through ...
The Canadian Press on MSN2d
Health Canada approves Pfizer-BioNTech's updated COVID-19 vaccinePfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...
The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and olderData demonstrate that the Omicron KP.2-adapted COVID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback